Literature DB >> 10102721

Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicate intracellular procalcitonin content.

M Oberhoffer1, H Vogelsang, L Jäger, K Reinhart.   

Abstract

PURPOSE: Procalcitonin is a new marker of severity of nonviral, in particular, bacterial infections. In respect of sepsis its site of production remains unknown. This study was carried out to determine whether subsets of human leukocytes contain procalcitonin.
MATERIALS AND METHODS: Blood samples of 17 patients who had demonstrated various degrees of serum procalcitonin levels on the day before evaluation were analyzed for serum procalcitonin by immunoluminometry and for intracellular reaction of monocytes, granulocytes, B-, and T-lymphocytes against katacalcin- or calcitonin-sensitive antibodies. Katacalcin and calcitonin are part of the procalcitonin molecule. Associations of these reactions with serum procalcitonin levels as well as differences between groups with a normal or elevated serum level were analyzed.
RESULTS: Intracellular antibody reaction against katacalcin was demonstrated in all cell types. We also found a lower rate of intracellular antibody reaction against calcitonin. Associations of serum procalcitonin with the two antibody reactions were demonstrated. Differences in intracellular reactions in the group with elevated serum procalcitonin were seen with both antibodies compared with a normal control.
CONCLUSION: Intracellular antibody reaction against katacalcin supports the notion that various types of leukocytes contain procalcitonin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10102721     DOI: 10.1016/s0883-9441(99)90005-9

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  9 in total

Review 1.  Immune regulation of procalcitonin: a biomarker and mediator of infection.

Authors:  G N Matwiyoff; J D Prahl; R J Miller; J J Carmichael; D E Amundson; G Seda; M Daheshia
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

2.  Diagnostic Accuracy of Cerebrospinal Fluid Procalcitonin in Bacterial Meningitis Patients with Empiric Antibiotic Pretreatment.

Authors:  Wen Li; Xiaolong Sun; Fang Yuan; Qiong Gao; Yue Ma; Yongli Jiang; Xiai Yang; Fang Yang; Lei Ma; Wen Jiang
Journal:  J Clin Microbiol       Date:  2017-02-08       Impact factor: 5.948

3.  One-step-immunoassay of procalcitonin enables rapid and accurate diagnosis of bacterial infection.

Authors:  Jae-Hwan Oh; Jung-Hyuk Kwon; Hye-Hyun Kim; Jeewon Lee
Journal:  RSC Adv       Date:  2021-06-17       Impact factor: 4.036

4.  Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria.

Authors:  H H Liu; M W Zhang; J B Guo; J Li; L Su
Journal:  Ir J Med Sci       Date:  2016-05-02       Impact factor: 1.568

Review 5.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

6.  Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review.

Authors:  Pedro Póvoa; Jorge I F Salluh
Journal:  Ann Intensive Care       Date:  2012-07-23       Impact factor: 6.925

7.  Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection.

Authors:  Anne-Marie Chaftari; Ray Hachem; Ruth Reitzel; Mary Jordan; Ying Jiang; Ammar Yousif; Kumait Garoge; Poonam Deshmukh; Zanaib Al Hamal; Joseph Jabbour; Alexander Hanania; Sammy Raad; Mohamed Jamal; Issam Raad
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

8.  N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients.

Authors:  Mariusz Piechota; Maciej Banach; Robert Irzmański; Małgorzata Misztal; Jacek Rysz; Marcin Barylski; Magdalena Piechota-Urbańska; Jan Kowalski; Lucjan Pawlicki
Journal:  Cell Mol Biol Lett       Date:  2006-12-06       Impact factor: 5.787

9.  Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial.

Authors:  Jianguo Tang; Wei Long; Lei Yan; Yu Zhang; Juan Xie; Gang Lu; Chunhui Yang
Journal:  BMC Infect Dis       Date:  2013-12-17       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.